Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
174
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Anteris Technologies Global Corp. market cap is $486.49M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anteris Technologies Global Corp. 52 week high is $11.06 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anteris Technologies Global Corp. 52 week low is $3.53 as of November 22, 2026.
Anteris Technologies Global Corp. stock price today is $4.99.
Anteris Technologies Global Corp. stock price yesterday was $5.09.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Anteris Technologies Global Corp.'s P/E ratio is -3.12.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Anteris Technologies Global Corp. P/B ratio is 2.1453.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Anteris Technologies Global Corp. 50-day moving average is $6.63.
Anteris Technologies Global Corp. has 174 employees.